Hidradenitis Suppurativa: Where We Are and Where We Are Going
Open accessThe DOI matches its Crossref record; 151 of the 152 references it cites were found in a registry or an index.
Abstract
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease primarily affecting apocrine gland-rich areas of the body. It is a multifactorial disease in which genetic and environmental factors play a key role. The primary defect in HS pathophysiology involves follicular occlusion of the folliculopilosebaceous unit, followed by follicular rupture and immune responses. Innate pro-inflammatory cytokines (e.g., IL-1β, and TNF-α); mediators of activated T helper (Th)1 and Th17 cells (e.g., IFN-γ, and IL-17); and effector mechanisms of neutrophilic granulocytes, macrophages, and plasma cells are involved. On the other hand, HS lesions contain anti-inflammatory mediators (e.g., IL-10) and show limited activity of Th22 cells. The inflammatory vicious circle finally results in pain, purulence, tissue destruction, and scarring. HS pathogenesis is still enigmatic, and a valid animal model for HS is currently not available. All these aspects represent a challenge for the development of therapeutic approaches, which are urgently needed for this debilitating disease. Available treatments are limited, mostly off-label, and surgical interventions are often required to achieve remission. In this paper, we provide an overview of the current knowledge surrounding HS, including the diagnosis, pathogenesis, treatments, and existing translational studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Progression leads to follicular rupture, with release of keratin, hair shaft fragments, and microbial products into the dermis [38,39].”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [38]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The presence of dermal tunnels is particularly useful in established diseases and distinguishes hidradenitis suppurativa from simple folliculitis or isolated abscesses.”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [38]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In more advanced lesions, the most characteristic and frequent histological finding is the presence of epithelium-lined sinus tracts or dermal tunnels, usually associated with chronic inflammation, granulation tissue, fibrosis, and scarring [38].”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [38]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Ruptured follicles trigger a dense mixed inflammatory infiltrate composed of neutrophils, lymphocytes, plasma cells, macrophages, and foreign-body giant cells. These are frequently seen in early lesions.”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [38]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Hidradenitis suppurativa is a chronic inflammatory disease characterized by painful nodules, abscesses, scarring, and a complex molecular and cellular landscape [38].”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [38]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interferon-γ: an overview of signals, mechanisms and functions
Schroder, K., Hertzog, P. J., Ravasi, T., & Hume, D. A. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0603252 · Cited by 4,120
Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
Agus, A., Planchais, J., & Sokol, H. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.05.003 · Cited by 3,180 · cited 1×
“In addition, a dysregulation of tryptophan catabolism (with overactivation of the kynurenine pathway and consequent stimulation of cytokines by inflammatory cell infiltrates) and of an aryl hydrocarbon receptor (AHR) (with impaired production of bacteria-derived AHR agonists and decreased incidence of AHR ligand-produ…”
BackgroundEuropean S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
Zouboulis, C. C., Desai, N., Emtestam, L., Hunger, R. E., Ioannides, D., Juhász, I., Lapins, J., Matusiak, L., Prens, E. P., Revuz, J., et al. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12966 · Cited by 1,093 · cited 4×
“No unrestricted recommendation can be given for the use of conventional immunosuppressant or immunomodulatory drugs including prednisolone [103], dapsone [104], retinoids [105], and ciclosporin [106], amongst others, as there is little or conflicting evidence for their efficacy [63,98].”
BackgroundInfluentialTwo Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
Kimball, A. B., Okun, M. M., Williams, D. A., Gottlieb, A. B., Papp, K. A., Zouboulis, C. C., Armstrong, A. W., Kerdel, F., Gold, M. H., Forman, S. B., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1504370 · Cited by 807
Revuz, J. E., Canoui-Poitrine, F., Wolkenstein, P., Viallette, C., Gabison, G., Pouget, F., Poli, F., Faye, O., Roujeau, J. C., Bonnelye, G., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.06.020 · Cited by 627
Sabat, R., Jemec, G. B. E., Matusiak, Ł., Kimball, A. B., Prens, E., & Wolk, K. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0149-1 · Cited by 573
Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity
Sartorius, K., Emtestam, L., Jemec, G. B. E., & Lapins, J. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09198.x · Cited by 525 · cited 3×
“Still today, the Hurley staging and the Sartorius scoring, together with HS Physician Global Assessment systems are the most commonly used assessment tools [22,23].”
BackgroundMethodZouboulis, C. C., Tzellos, T., Kyrgidis, A., Jemec, G. B. E., Bechara, F. G., Giamarellos‐Bourboulis, E. J., Ingram, J. R., Kanni, T., Karagiannidis, I., Martorell, A., et al. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15748 · Cited by 493
Hidradenitis Suppurativa: Advances in Diagnosis and Treatment
Saunte, D. M. L., & Jemec, G. B. E. (2017) · JAMA · doi:10.1001/jama.2017.16691 · Cited by 492 · cited 1×
“Independent of the duration and severity of HS, all patients should follow basic therapeutic measures, including self-education about the disease, pain management, maintaining high hygiene standards, cessation of smoking, and losing weight, amongst others [1,96].”
Backgroundvan der Zee, H. H., de Ruiter, L., van den Broecke, D. G., Dik, W. A., Laman, J. D., & Prens, E. P. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10254.x · Cited by 472 · cited 3×
“sion of NRLP3 as well as IL-1β were detected in HS lesions [75,77,78].”
Background
Cited by
Roy, T., Boateng, S. T., Uddin, M. B., Banang-Mbeumi, S., Yadav, R. K., Bock, C. R., Folahan, J. T., Siwe-Noundou, X., Walker, A. L., King, J. A., et al. (2023) · Cells · doi:10.3390/cells12121671 · Cited by 161
Hidradenitis suppurativa: new insights into disease mechanisms and an evolving treatment landscape
Krueger, J. G., Frew, J. W., Jemec, G. B. E., Kimball, A. B., Kirby, B., Bechara, F. G., Navrazhina, K., Prens, E. P., Reich, K., Cullen, E., et al. (2023) · British Journal of Dermatology · doi:10.1093/bjd/ljad345 · Cited by 132
Krajewski, P. K., Złotowska, A., & Szepietowski, J. C. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13216292 · Cited by 83
“…such as IL-1βand TNF-α, along with mediators from activated Th1 and Th17 helper cells (including IFN-γ and IL-17), and effector mechanisms involving neutrophils, and Th17 helper cells (including IFN-γ and IL-17), and effector mechanisms involving neutrophils, macrophages and plasma cells [17–19].”
BackgroundBurden of Hidradenitis Suppurativa: A Systematic Literature Review of Patient Reported Outcomes
Kimball, A. B., Kirby, J. S., Ingram, J. R., Tran, T., Pansar, I., Ciaravino, V., Willems, D., Lewis-Mikhael, A.-M., Tongbram, V., & Garg, A. (2024) · Dermatology and Therapy · doi:10.1007/s13555-023-01085-w · Cited by 55
“HS can have a profound negative impact on patients’ health-related quality of life (HRQoL), mainly due to the high disease burden resulting from symptoms, delays in diagnosis limited access to appropriate disease management, and disease-related comorbidity profile [2–5].”
BackgroundPathogenesis of Inflammation in Skin Disease: From Molecular Mechanisms to Pathology
Shirley, S. N., Watson, A. E., & Yusuf, N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810152 · Cited by 74
“Besides the associated pain and itching, the malodorous purulent discharge from ruptured follicles and the extensive scarring cause social embarrassment and isolation for many patients [55].”
BackgroundPetrasca, A., Hambly, R., Kearney, N., Smith, C. M., Pender, E., Mahon, J. M., O’Rourke, A. M., Ismaiel, M., Boland, P. A., Almeida, J. P., et al. (2023) · British Journal of Dermatology · doi:10.1093/bjd/ljad305 · Cited by 53
Jenkins, T., Isaac, J., Edwards, A., & Okoye, G. A. (2023) · Dermatologic Clinics · doi:10.1016/j.det.2023.02.001 · Cited by 40
Caccavale, S., Tancredi, V., Boccellino, M. P., Babino, G., Fulgione, E., & Argenziano, G. (2023) · Life · doi:10.3390/life13010189 · Cited by 51
“Beyond monoclonal antibodies, new therapies include: apremilast, a phosphodiesterase-4 inhibitor and Janus kinase (JAK) signaling blockers such as tofacitinib and upadacitinib [10].”
BackgroundThe role of interleukin‐36 in health and disease states
Sugiura, K., Fujita, H., Komine, M., Yamanaka, K., & Akiyama, M. (2024) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.19935 · Cited by 48
“1,78,79 HS is characterized by fistula formation and neutrophilic inflammation, which may involve both inflammation and disrupted epithelial development and/or structure with progression to chronically draining tunnels in later-stage disease.”
Hidradenitis suppurativa flares following COVID-19 vaccination: A case series
Martora, F., Picone, V., Fabbrocini, G., & Marasca, C. (2022) · JAAD Case Reports · doi:10.1016/j.jdcr.2022.03.008 · Cited by 39
“frequent comorbidities and inadequate response to currently available therapies.(7)”
Self-citationThe Sebaceous Gland: A Key Player in the Balance Between Homeostasis and Inflammatory Skin Diseases
Mosca, S., Ottaviani, M., Briganti, S., Nardo, A. D., & Flori, E. (2025) · Cells · doi:10.3390/cells14100747 · Cited by 44
“…receptors, the upregulation of the (NOD)-like receptor protein 3 (NLRP3) inflammasome, dysregulated keratinocyte function, and impaired Notch signalling [200,201,204–206], which plays a crucial role in the differentiation of hair follicle and maintenance of skin appendages, including SGs [203].”
Molinelli, E., Gioacchini, H., Sapigni, C., Diotallevi, F., Brisigotti, V., Rizzetto, G., Offidani, A., & Simonetti, O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098428 · Cited by 42
Sexual Dysfunction and Quality of Life in Patients with Hidradenitis Suppurativa and Their Partners
Cuenca‐Barrales, C., Montero‐Vílchez, T., Krajewski, P. K., Szepietowski, J. C., Matusiak, Ł., Arias‐Santiago, S., & Molina‐Leyva, A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20010389 · Cited by 27
Heidari, A., Ghane, Y., Heidari, N., Sadeghi, S., & Goodarzi, A. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111435 · Cited by 28
Vitamin D in the Prevention and Treatment of Inflammatory Skin Diseases
Mokoš, Z. B., Krsnik, L. T., Harak, K., Tomić, D. M., Perković, D. T., & Vukojević, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115005 · Cited by 34
“Mechanical stress, smoking, and the cutaneous microbiome are environmental factors that contribute to the pathogenesis of HS. Mechanical stress primarily refers to increased friction in the skin folds [172].”
Chang, H., Wu, C., Chiu, T., Liao, W., & Gau, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1285560 · Cited by 28
“This, in turn, prompts keratinocytes to produce in fl ammatory mediators such as antimicrobial peptides and cytokines, which could drive in fl ammation and recruit immune cells (14, 35).”
BackgroundVaillant, C., Berkane, Y., Lupon, E. L., Atlan, M., Rousseau, P., Lellouch, A. G., Duisit, J., & Bertheuil, N. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11195813 · Cited by 23
Cestari, M. D. C. P., Tovo, R. F., & Bueno, D. F. (2025) · International Journal of Dermatology · doi:10.1111/ijd.17982 · Cited by 31
“Its pathogenesis involves follicular occlusion, dysregulated cytokines—especially TNF-α and IL-1β—and persistent immune activation, contributing to chronic inflammation and defective wound healing [142, 143].”
Obesity in Hidradenitis Suppurativa: Are GLP-1 Receptor Agonists the New Frontier?
Strong, J., & Driscoll, M. S. (2024) · American Journal of Clinical Dermatology · doi:10.1007/s40257-024-00911-x · Cited by 22
“Typical lesions include comedones, nodules, abscesses, and sinus tracts in intertriginous areas of the body such as the axilla, infra-and inter-mammary, inguinal and gluteal regions [1].”
InfluentialIngram, J. R., Marzano, A. V., Prens, E. P., Schneider‐Burrus, S., Warren, R. B., Keal, A., Jha, R., Daly, A. C. H., & Kimball, A. B. (2025) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.20550 · Cited by 19
Cedirian, S., Donati, M., Rapparini, L., Pampaloni, F., Plaça, M. L., Sgarzani, R., Negosanti, L., Raschi, E., & Starace, M. V. R. (2025) · Dermatology and Therapy · doi:10.1007/s13555-025-01537-5 · Cited by 28
“Pro-inflammatory cytokines (e.g., IL-1 β and TNF α ), mediators of Th1 and Th17 cells (e.g., IFN γ and IL-17), and effector mechanisms involving neutrophils, macrophages, and plasma cells are all implicated in the disease process [28, 29].”
Garg, A., Naik, H. B., & Kirby, J. S. (2022) · The American Journal of Medicine · doi:10.1016/j.amjmed.2022.09.025 · Cited by 18
The role of imaging technologies in the diagnosis of hidradenitis suppurativa
Nazzaro, G., Calzari, P., Vaienti, S., Passoni, E., & Marzano, A. V. (2023) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2023.08.023 · Cited by 23
Li, Y., Speck, P. J., Viera, E., Siira, M. R., & Orenstein, L. A. V. (2023) · Dermatology · doi:10.1159/000533740 · Cited by 17
Heidari, N., Heidari, A., Eghbali, S., Pishraft-sabet, H., Hajikarim‐Hamedani, A., Ghane, Y., Lotfi, Z., & Goodarzi, A. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103818 · Cited by 15
The Role of Tumor Microenvironment in the Pathogenesis of Sézary Syndrome
Miyashiro, D., Souza, B. D. C. E., Torrealba, M. P., Manfrere, K. C. G., Sato, M. N., & Sanches, J. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020936 · Cited by 16
Davydova, A., Kurochkina, Y. D., Goncharova, V. E., Vorobyeva, M., & Korolev, M. A. (2023) · Biomedicines · doi:10.3390/biomedicines11051328 · Cited by 16
Scala, E., Mercurio, L., Albanesi, C., & Madonna, S. (2024) · Life · doi:10.3390/life14060733 · Cited by 20
“In the future, our goal is to investigate the involvement of adipokines in hidradenitis suppurativa [140], a chronic inflammatory skin condition associated with obesity that remains poorly understood.”
BackgroundSelf-citationSpesolimab, the first‐in‐class anti‐ IL ‐ 36R antibody: From bench to clinic
Morita, A., Okubo, Y., Imafuku, S., & Terui, T. (2024) · The Journal of Dermatology · doi:10.1111/1346-8138.17449 · Cited by 16
“52 A genetic basis for HS has been identified in some families with history of HS. 52,59–63 The earliest mutation identified in families with HS was in γ - secretase, an endoprotease complex that cleaves nu - merous Type-1 transmembrane proteins and is encoded by several genes, including NCSTN ,…”
Sadeghi, S., & Goodarzi, A. (2022) · Dermatology Practical & Conceptual · doi:10.5826/dpc.1204a178 · Cited by 16
Impact of Hidradenitis Suppurativa Surgical Treatment on Health-Related Life Quality
Gierek, M., Kitala, D., Łabuś, W., Szyluk, K., Niemiec, P., & Ochała-Gierek, G. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154327 · Cited by 14
Molinelli, E., Gioacchini, H., Marani, A., Rizzetto, G., Gambini, D., SIMONI, E. D., Offidani, A., & Simonetti, O. (2024) · Dermatology and Therapy · doi:10.1007/s13555-024-01169-1 · Cited by 20
Dattolo, A., Torres, M., Frías-Toral, E., Paganelli, A., Zhang, M., Madonna, S., Mercurio, L., Cucalón, G., Garbarino, F., Albanesi, C., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06175-1 · Cited by 17
“Moreover, the presence of the anti-inflammatory mediator IL-10 in HS lesions, along with limited Th22 activity, may contribute to the reduction of antimicrobial peptides (AMPs), and thereby increase susceptibility to infections [11].”
InfluentialSelf-citationPlant-Based Foods for Chronic Skin Diseases: A Focus on the Mediterranean Diet
Annunziata, G., Verde, L., Zink, A., Muscogiuri, G., Albanesi, C., Paganelli, A., Barrea, L., & Scala, E. (2025) · Current Nutrition Reports · doi:10.1007/s13668-025-00632-5 · Cited by 21
“The pathophysiology of HS involves follicular occlusion, inflammation, immune system dysregulation, bacterial infection and colonization, abnormal secretion from apocrine glands, and alterations in antimicrobial peptide expression [4].”
InfluentialSelf-citationMicroRNA Cross-Involvement in Acne Vulgaris and Hidradenitis Suppurativa: A Literature Review
Borgia, F., Peterle, L., Custurone, P., Vaccaro, M., Pioggia, G., & Gangemi, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063241 · Cited by 15
Patient Preferences in Hidradenitis Suppurativa (APProach‐HS): a discrete choice experiment
Faverio, K., Peitsch, W. K., Görig, T., Schneider‐Burrus, S., Benzel, F., Goebeler, M., Schummer, P., Badran, A., Schaarschmidt, M., Harth, W., et al. (2022) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14886 · Cited by 13
Targeted therapy for immune mediated skin diseases. What should a dermatologist know?
López, E., Cabrera, R., & Lecaros, C. (2024) · Anais Brasileiros de Dermatologia · doi:10.1016/j.abd.2023.10.002 · Cited by 17
Peripheral ulcerative keratitis secondary to severe hidradenitis suppurativa
Dallalzadeh, L. O., Ang, M. J., Beazer, A. P., Spencer, D., & Afshari, N. A. (2022) · American Journal of Ophthalmology Case Reports · doi:10.1016/j.ajoc.2022.101403 · Cited by 10
Rached, N. A., Dietrich, J. W., Ocker, L., Quast, D. R., Scheel, C., Gambichler, T., & Bechara, F. G. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12237490 · Cited by 11
“There is limited evidence that thyroid hormones may be involved in the inflammatory response [18].”
BackgroundGierek, M., Bergler-Czop, B. S., Słaboń, A., Łabuś, W., & Ochała-Gierek, G. (2023) · Advances in Dermatology and Allergology · doi:10.5114/ada.2023.126323 · Cited by 9
“Moreover, neutrophils, macrophages and plasma cells are involved in the development of the disease [6].”
BackgroundNilforoushzadeh, M. A., Heidari, N., Heidari, A., Ghane, Y., Hosseini, S., Lotfi, Z., Jaffary, F., Nobari, M. N., Aghamiri, Z. S., & Nobari, N. N. (2024) · Lasers in Medical Science · doi:10.1007/s10103-024-04077-0 · Cited by 9
Marzano, A. V., Magnoni, C., Micali, G., Magnis, A. D., Pintori, G., Fiorini, S., Simonella, V., Bastioli, L., Nappi, F., Pappagallo, G. L., et al. (2024) · Archives of Dermatological Research · doi:10.1007/s00403-024-03316-2 · Cited by 8
“Considering that knowledge of underlying HS pathogenetic mechanisms is still lacking, phenotypic variants could be revised in the future [30].”
BackgroundMethodInfluentialGau, S., Guo, Y.-C., Lu, H.-Y., Lin, C.-Y., Lee, C., Tsai, R., Chang, H., Wu, M., & Li, C.-P. (2024) · International Journal of Medical Sciences · doi:10.7150/ijms.93178 · Cited by 8
“The etiology of HS is multifaceted, involving genetics, hormonal factors, innate immunity, and environmental influences [19].”
BackgroundIncreased Serum Levels of S100A4 and S100A15 in Individuals Suffering from Hidradenitis Suppurativa
Batycka-Baran, A., Matusiak, Ł., Nowicka‐Suszko, D., Szepietowski, J. C., & Baran, W. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10225320 · Cited by 8
Bulger, D. A., Zhang, Z., Hu, R., Dave, E. K., Mehta, P. K., Griendling, K. K., & Valdivia, A. (2025) · Antioxidants and Redox Signaling · doi:10.1177/15230864251372607 · Cited by 8
Heidari, A., Ghane, Y., Heidari, N., Hosseini, S., & Goodarzi, A. (2024) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223241257342 · Cited by 7
The Composition of Subgingival Microbiome in Hidradenitis Suppurativa and Periodontitis Patients
Jastrząb, B., Paśnik-Chwalik, B., Dębska-Łasut, K., Konopka, T. P., Krajewski, P. K., Szepietowski, J. C., & Matusiak, Ł. (2023) · Pathogens · doi:10.3390/pathogens12030377 · Cited by 7
Bellei, E. A., Shirozaki, M. E. M., Puglia, A. L. P., de Carvalho, A. V. E., Riquena, B., Vallilo, C. C., de Barros, D. H., Tamashiro, E. Y., Cintra, G., Duarte, G. V., et al. (2023) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s420750 · Cited by 7
“their life.(4,5) High rates of depression and anxiety have been reported in HS patients, also including indirect selfdestructiveness, chronic pain, damaging effects on sexual health, and a nearly 2.”
Therapies for hidradenitis suppurativa: a systematic review with a focus on Brazil
Machado, M. C. R., Magalhães, R. F., da Silva, R. S., Duarte, G. V., Bosnich, F. Z., Tunala, R., & Forestiero, F. (2022) · Drugs in Context · doi:10.7573/dic.2021-9-6 · Cited by 8
Kaya, G., Özgen, F. P., Kelahmetoğlu, O., Su, Ö., & Onsun, N. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2024.1499509 · Cited by 5
Discovering KYNU as a feature gene in hidradenitis suppurativa
Chen, L., Yu, Y. Y., Tang, Q., & Shen, L. (2023) · International Journal of Immunopathology and Pharmacology · doi:10.1177/03946320231216317 · Cited by 5
“31,32 Gentamicin, Ibudilast, Spironolactone, Trastuzumab, Thalidomide, Apremilast, Glucosamine, Interferon-alpha-2b, Binimetinib, and Midostaurin have previously been identi fi ed as repurposed drugs for the treatment of HS. 33 SLAMF7, identi fi ed as one of the DEGs in our study, is primarily…”
BackgroundFactors Associated with Severe Hidradenitis Suppurativa, Using Hurley Staging and Metascore
Daoud, M., Suppa, M., Benhadou, F., Heudens, S., Sarkis, A.-S., Njimi, H., Saunte, S. K., Desmarest, L., Cano, C. O., Dandoy, C., et al. (2024) · Dermatology · doi:10.1159/000541052 · Cited by 5
“…altered innate immunity (stimulation of neutrophil chemoattraction and increased production of numerous cytokines by keratinocytes), slowed wound healing [7, 17, 18], and possibly via an in fl uence on the microbiota and dysbiosis [19], the link between which and HS is as yet poorly de fi ned [20].”
LncRNA microarray profiling identifies novel circulating lncRNAs in hidradenitis suppurativa
Felice, B. D., Luca, P. D., Montanino, C., Mallardo, M., Babino, G., Mattera, E., Sorbo, R., Ragozzino, G., Argenziano, G., Daniele, A., et al. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13236 · Cited by 6
“…this reason, screening is recommended if certain conditions or clinico‑pathological characteristics are met in the patients, such as acne, pyoderma gangrenosum, smoking, polycystic ovary syndrome, cardiovascular disease, metabolic diseases, inflam‑ matory bowel disease and spondyloarthritis (19).”
BackgroundMartora, F., Tommasino, N., Brescia, C., Potestio, L., Battista, T., & Megna, M. (2024) · Medicina · doi:10.3390/medicina60091465 · Cited by 5
“The mean age of onset is be-tween the second and third decade, but it can appear at any age [11].”
BackgroundSelf-citationInfliximab inhibits TNF-α-dependent activation of the NLRP3/IL-1β pathway in acne inversa
He, Y., Wang, W., Jiang, J., Yuan-xing, S., Wang, B., Chen, J., Li, M., & Xu, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e33146 · Cited by 4
“TNF-α plays essential proinflammatory roles in the skin, and is produced by immune cells and keratinocytes [19].”
BackgroundAli, W., Williams, J., Xiong, B., Zou, J., & Daneshjou, R. (2025) · JID Innovations · doi:10.1016/j.xjidi.2025.100362 · Cited by 4
Scheel, C., Rached, N. A., & Gambichler, T. (2022) · British Journal of Dermatology · doi:10.1111/bjd.21591 · Cited by 4
Soto‐Moreno, A., Cuenca‐Barrales, C., Arias‐Santiago, S., García-Vidal, J. A., Medina‐Mirapeix, F., & Molina‐Leyva, A. (2024) · Dermatology and Therapy · doi:10.1007/s13555-024-01149-5 · Cited by 4
The interleukin-1 pathway as a treatment target in early-stage hidradenitis suppurativa?
Suhrkamp, I., & Gerdes, S. (2023) · British Journal of Dermatology · doi:10.1093/bjd/ljad225 · Cited by 4
Misfortunes never come singly but in fours – follicular occlusion tetrad
Łanocha, M., Frątczak, A., Tekielak, A., Miziołek, B., & Bergler-Czop, B. S. (2024) · Advances in Dermatology and Allergology · doi:10.5114/ada.2024.138652 · Cited by 3
“Furthermore, patients with hidradenitis suppurativa are at risk of developing components of the metabolic syndrome [5].”
BackgroundKaya, K., & Gevher, Ö. D. (2024) · Cutaneous and Ocular Toxicology · doi:10.1080/15569527.2024.2387595 · Cited by 3
Sahl, R. E., Poggi, A. I., Nielsen, V. W., Yao, Y., Patsi, I., Poulsen, S. S., Dela, F., Larsen, S., Thomsen, S. F., & Helge, J. W. (2024) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70002 · Cited by 3
Marzano, A. V., Bartoletti, M., Bettoli, V., Bianchi, L., Chiricozzi, A., Clerici, M., Dapavo, P., Dini, V., Foti, C., Magnoni, C., et al. (2025) · Archives of Dermatological Research · doi:10.1007/s00403-025-04016-1 · Cited by 4
“Elevations of several pro-inflammatory cytokines, including TNF-α, IL-1β, IL-23 and IL-17, have been found in HS lesions, both at the level of gene expression and mRNA expression [1, 69].”
Self-citationUnlocking the Mechanisms of Hidradenitis Suppurativa: Inflammation and miRNA Insights
Ames, E., Sanders, M., Jacobs, M., & Vida, T. A. (2024) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s483871 · Cited by 4
“9 Although follicular occlusion is known to trigger HS, the exact initiating factors remain poorly understood.”
InfluentialImpact of Hidradenitis Suppurativa on Sexual Quality of Life
Caliezi, A., Rabufetti, A., Hunger, R. E., Wolf, R., & Jafari, S. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14030910 · Cited by 4
A Familial Form of Epidermolysis Bullosa Simplex Associated with a Pathogenic Variant in KRT5
Paduano, F., Colao, E., Grillone, T., Vismara, M. F. M., Amato, R., Nisticò, S. P., Mignogna, C., Dastoli, S., Fabiani, F., Zucco, R., et al. (2021) · Genes · doi:10.3390/genes12101503 · Cited by 3
Systematic review of laser and Light-Based procedural treatments for hidradenitis suppurativa
Jafarzadeh, A., Torkaman, N., Boroujeni, D. H., & Goodarzi, A. (2025) · Lasers in Medical Science · doi:10.1007/s10103-025-04722-2 · Cited by 2
Eşme, P., & Maden, A. (2022) · Dermatology Practical & Conceptual · doi:10.5826/dpc.1204a208 · Cited by 3
The Role of FDG-PET in the Evaluation of Hidradenitis Suppurativa: A Systematic Review
Talasila, S., Teichner, E. M., Subtirelu, R. C., Xiang, D. H., Ayubcha, C., Werner, T. J., Alavi, A. A., & Revheim, M.-E. R. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12175491 · Cited by 2
A Rare Case of Pregnancy After Surgical Treatment for Stage III Hidradenitis Suppurativa
Nalla, S. D., Kurakula, S., & Siddaraju, M. N. (2023) · Cureus · doi:10.7759/cureus.45370 · Cited by 2
“While the etiology of hidradenitis suppurativa is elusive, research has shown that it could be due to an amalgam of immune system dysregulation, genetics, and lifestyle factors such as cigarette smoking, obesity, and stress [3].”
BackgroundPlasmablastic lymphoma masked by hidradenitis suppurativa
Preis, S., Kain, A., Biedermann, T., & Volz, T. (2022) · JAAD Case Reports · doi:10.1016/j.jdcr.2022.06.016 · Cited by 2
“In HS, the immune defense does not suffice in containing the inflammation but rather leads to a systemic inflammatory response.(3) Thus, increased concentrations of tumor necrosis factor-alpha, interleukin (IL)-1, IL-17, and IL-23 are detectable in the serum of HS patients.”
BackgroundSelf-citationStep by step surgery for hidradenitis suppurativa
Guida, A. D., Forgione, P., Fornaro, L., Marasca, D., Fabbrocini, G., & Marasca, C. (2022) · Dermatologic Therapy · doi:10.1111/dth.15938 · Cited by 2
“Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease affecting 1% of the population, with a female prevalence.(1) Management of HS may be challenging since the lack of effective treatments.”
BackgroundSelf-citationTinca, A. C., Cozac-Szoke, A. R., & Cotoi, O. S. (2026) · Dermatopathology · doi:10.3390/dermatopathology13020022 · Cited by 1
“Progression leads to follicular rupture, with release of keratin, hair shaft fragments, and microbial products into the dermis [38,39].”
InfluentialExploring the connection between hidradenitis suppurativa and erythema nodosum: a case report
Hanson, M., Maloney, M. E., & Kuchnir, L. (2024) · Dermatology Reports · doi:10.4081/dr.2024.9866 · Cited by 1
Zhang, Q.-J., Feng, Y., Chen, X., Mo, X., Wu, Q., & Ju, Q. (2024) · International Journal of Dermatology and Venereology · doi:10.1097/jd9.0000000000000382 · Cited by 1
Olaoye, I., & Casado, A. (2024) · Journal of Dermatology for Physician Assistants · doi:10.1097/jdpa.0000000000000042 · Cited by 1
Nursing Knowledge and Skills in Hidradenitis Suppurativa: A Multi-Centre Exploratory Study
Vilanova‐Trillo, L., Martinez‐Santos, A., de la Iglesia, J. D. C. F., Salgado‐Boquete, L., & Flórez, Á. (2025) · Nursing Reports · doi:10.3390/nursrep15020040 · Cited by 1
“Although the aetiology remains unclear, it is considered a multifactorial disease where genetic, immunological, and environmental factors play a key role [2,3].”
Racial Disparities in Hidradenitis Suppurativa Management at a Single Institution
Singh, N. P., Burge, K. G., Drummond, S. C., Zaniewski, R., MacLeod, S., Moradi, L., Hattaway, R., King, T. W., Mayo, T. T., & de la Torre, J. I. (2025) · Plastic & Reconstructive Surgery Global Open · doi:10.1097/gox.0000000000006803 · Cited by 1
Gel Antiperspirants for Hidradenitis Suppurativa: A Pilot Study
Rosenberg, A., Gottlieb, C., Luba, J., Abramovits, W., Cockerell, C. J., Rigel, D. S., & Smythe, C. (2025) · SKIN The Journal of Cutaneous Medicine · doi:10.25251/k4j6p744 · Cited by 1
New Biologic and Small Molecule Therapies for Hidradenitis Suppurativa
Pender, E., Hughes, R., & Kirby, B. (2026) · JEADV Clinical Practice · doi:10.1002/jvc2.70268 · Cited by 1
New Frontiers of Skin Ultrasound in Precision Medicine
tiu, D. I., Wortsman, X., Scurtu, L. G., & Simionescu, O. (2026) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2026.05.015 · Cited by 2
Vilarrasa, E., Garbayo‐Salmons, P., Masferrer, E., Corral, O., Mora‐Fernández, V., Bassas‐Vila, J., Luque, M., Fuertes, I., Fornons‐Servent, R., Martín‐Ezquerra, G., et al. (2026) · Dermatology and Therapy · doi:10.1007/s13555-026-01900-0 · Cited by 1
“The pathogenesis of HS is multifactorial, involving genetic predisposition, microbiome alterations, immune dysregulation, hormonal influences, obesity, smoking, and skin occlusion [2, 3, 7–9].”
Patientenpräferenzen bei Hidradenitis suppurativa (APProach‐HS): ein “Discrete‐Choice”‐Experiment
Faverio, K., Peitsch, W. K., Görig, T., Schneider‐Burrus, S., Benzel, F., Goebeler, M., Schummer, P., Badran, A., Schaarschmidt, M., Harth, W., et al. (2022) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14886_g · Cited by 1
Advances in surgical treatment of hidradenitis suppurative
Wang, Y., Han, C., & Xingang, W. A. N. G. (2023) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2023-0326 · Cited by 1
Rymaszewska, J. E., Karczewski, M., Krajewski, P. K., Matusiak, Ł., Maj, J., & Szepietowski, J. C. (2023) · Healthcare · doi:10.3390/healthcare11243139 · Cited by 1
Tlish, M. M., Георгиевна, К. Т., Юрьевна, Н. Ж., & Сычева, Н. Л. (2023) · Кубанский научный медицинский вестник · doi:10.25207/1608-6228-2023-30-6-89-101 · Cited by 1
Hidradenitis Supurativa glútea y perineal: diagnóstico y manejo terapéutico
Trostchansky, I., Clavijo, L., Garrel, M., Geribaldi, N., & Valiñas, R. (2024) · Cirugía del Uruguay/Cirugía del Uruguay · doi:10.31837/cir.urug/8.1.7
Future directions in hidradenitis suppurativa
Leiphart, P. A., & Kirby, J. S. (2022) · Dermatological Reviews · doi:10.1002/der2.124 · Cited by 1
“While there are no trials using combination immunomodulators for HS, there is a Phase IV trial that demonstrated the safety and efficacy of adalimumab with surgical therapy of HS.33 The evidence supporting combination immunomodulator therapy for HS is limited to case reports.”
BackgroundMethodInfluentialHidradenitis Suppurativa Perineal and Perianal
Luporini, R. L., Frizol, S. M., Segantini, M. J., Pereira, L. D., Fontanella, A. P., & Féres, O. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.105632 · Cited by 1
Die Rolle des PI3-K/Akt/mTOR-Signalwegs in der Acne inversa
Dmitriev, A. (2022) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) · doi:10.21248/gups.71262
Hidradenitis Suppurativa: Managing a Complex Disease with Multiple Comorbidities
Smith, S. M. (2022) · Journal of Dermatology for Physician Assistants · doi:10.58744/001c.70416
Editorial: Updates on hidradenitis suppurativa – Pathogenesis, diagnosis and treatment
Scala, E., & Zink, A. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1209545
Self-citationSula, B., & EKİNCİ, Ü. (2023) · Turkiye Klinikleri Journal of Medical Sciences · doi:10.5336/medsci.2022-93830
Ziegler, U. E., Sakova, P., & Reith, H. B. (2023) · Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie · doi:10.1055/a-2109-3015
“Zu den anerkannten Triggerfaktoren der HS gehört der Nikotinabusus [12, 37, 38, 39, 40, 41].”
KAYA, Ö. B., & ÇİNPOLAT, H. Y. (2023) · Medical Journal of Western Black Sea · doi:10.29058/mjwbs.1278387
Somani, A.-K. B., Atkin, L., Bechara, F. G., Davidson, J. M., Jeffery, S., Mostow, E. N., Simman, R., Armstrong, D. G., Karatzias, A., Lázaro‐Martínez, J. L., et al. (2023) · Journal of Wound Care · doi:10.12968/jowc.2023.32.sup9b.s1
Lai, X., Zhang, H., Zhang, C., Wang, M., Yang, Y., Chen, W., Wang, B., & Yan, Y. (2024) · Research Square · doi:10.21203/rs.3.rs-3929640/v1
Hidradenitis Suppurativa: Surgical Management
Finkelstein, E. R., Witter, A., Mason, M. C., & Danker, S. (2024) · Springer eBooks · doi:10.1007/978-3-031-48503-9_51
Hidradenite supurativa: uma revisão da literatura
Silva, G. S., Gloria, G. B., Cavalcanti, A. L. P., Casimiro, M. K. R., & Oliveira, A. L. (2024) · Journal Archives of Health · doi:10.46919/archv5n3espec-339
Asemptomatik hiperüriseminin hidradenitis süppürativa hastalık seyrine etkileri
Bakay, Ö. S. K., & Bakay, U. (2024) · Turkish Journal of Clinics and Laboratory · doi:10.18663/tjcl.1529053
Metadata
- Authors
- Scala, E., Cacciapuoti, S., Garzorz-Stark, N., Megna, M., Marasca, C., Seiringer, P., Volz, T., Eyerich, K., & Fabbrocini, G.
- Affiliations
- Karolinska Institutet (SE)
- University of Naples Federico II (IT)
- Division of Dermatology and Venereology, Department of Medicine Solna and Center for Molecular Medicine, Karolinska Institutet, 17176 Stockholm, Sweden
- Technical University of Munich (DE)
- Karolinska University Hospital (SE)
- Corresponding author
- Scala, Emanuele
- ORCID
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2021-08-15
- Volume
- 10
- Issue
- 8
- Pages
- 2094
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC8392140
- OpenAlex
- W3195421093
- Semantic Scholar
- 304c292cd74070067b2680ed72014e3741c3c074
- Cited by
- 135
- References
- 152
- Citations by year
- 2026: 24 · 2025: 31 · 2024: 31 · 2023: 27 · 2022: 20 · 2021: 2
- FWCI
- 3.54
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion, other-oa)
- Site cant be reached (submittedVersion, cc-by)
- Funders
- Technische Universität München
- Topics
- Health Sciences › Medicine › Dermatology › Hidradenitis Suppurativa and Treatments
- Health Sciences › Medicine › Dermatology › Autoimmune and Inflammatory Disorders
- Health Sciences › Medicine › Rheumatology › Osteomyelitis and Bone Disorders Research
- Keywords
- hidradenitis suppurativa, pathogenesis, follicular occlusion, apocrine glands, inflammatory cytokines, Th17 cells, Th22 cells, neutrophils, IL-17, TNF-α, IL-10, immune dysregulation, animal models, diagnosis, treatment, surgical treatment, chronic inflammatory skin disease
- MeSH terms
- Anti-Inflammatory Agents, Combined Modality Therapy, Humans, Inflammation, Skin, Biomarkers, Cytokines, Hidradenitis Suppurativa
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.